NRG1 and schizophrenia: This cascade is clinically relevant since disruption of Nrg1-ErbB4 signaling is associated with epilepsy, intellectual disability and schizophrenia (Li et al., 2011; Tan et al., 2011; Marin, 2012; Del Pino et al., 2013; Hyder et al., 2021).